Profile
Hans Glemstedt formerly worked at Biovitrum AB, as Director, Silex Microsystems AB, as Director, Swedish Orphan Biovitrum AB, as Director from 2009 to 2011, and Startupfactory AB, as Managing Partner.
Mr. Glemstedt received his graduate degree from Stockholm School of Economics.
Former positions of Hans Glemstedt
Companies | Position | End |
---|---|---|
SWEDISH ORPHAN BIOVITRUM AB | Director/Board Member | 27/04/2011 |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Director/Board Member | 12/05/2010 |
Startupfactory AB
Startupfactory AB Investment ManagersFinance Startupfactory is an early stage Nordic venture capital firm based in Stockholm investing in Nordic companies and teams in the IT, datacom and telecom industries. The people at Startupfactory have long experience from building companies in the IT, datacom and telecom industries and know that building companies takes long time and requires unexpected amounts of energy and work. Starupfactory is currently focusing on development of its current portfolio of companies. | Corporate Officer/Principal | 17/01/2007 |
Silex Microsystems AB
Silex Microsystems AB Electronic Production EquipmentElectronic Technology Silex Microsystems AB is a holding company that manufactures customized Micro Electro Mechanical Systems (MEMS) products. The firm operates as an independent MEMS foundry. Its product MEMS, which are complex mechanical and electrical systems are built in micro scale on one single chip. Its product is divided in categories such as: sensors, actuators, and basic three-dimensional structures. The company was founded by Johan Edvard Soren Kalvesten in October 2000 and is headquartered in Jarfalla, Sweden. | Director/Board Member | - |
Training of Hans Glemstedt
Stockholm School of Economics | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
Private companies | 3 |
---|---|
Startupfactory AB
Startupfactory AB Investment ManagersFinance Startupfactory is an early stage Nordic venture capital firm based in Stockholm investing in Nordic companies and teams in the IT, datacom and telecom industries. The people at Startupfactory have long experience from building companies in the IT, datacom and telecom industries and know that building companies takes long time and requires unexpected amounts of energy and work. Starupfactory is currently focusing on development of its current portfolio of companies. | Finance |
Silex Microsystems AB
Silex Microsystems AB Electronic Production EquipmentElectronic Technology Silex Microsystems AB is a holding company that manufactures customized Micro Electro Mechanical Systems (MEMS) products. The firm operates as an independent MEMS foundry. Its product MEMS, which are complex mechanical and electrical systems are built in micro scale on one single chip. Its product is divided in categories such as: sensors, actuators, and basic three-dimensional structures. The company was founded by Johan Edvard Soren Kalvesten in October 2000 and is headquartered in Jarfalla, Sweden. | Electronic Technology |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Commercial Services |
- Stock Market
- Insiders
- Hans Glemstedt